GO:0052810 1-phosphatidylinositol-5-kinase activity

Phosphoinositides are minor membrane phospholipids that act as signaling hubs, and the enzyme activity defined by GO:0052810, 1-phosphatidylinositol-5-kinase activity, catalyzes the phosphorylation of phosphatidylinositol at the D-5 position of the inositol ring to generate phosphatidylinositol 5-phosphate (PI5P). This activity is biochemically and functionally distinct from the canonical PI4P 5-kinases that produce PI(4,5)P2, and it represents a direct route to PI5P, a lipid that has emerged as a critical regulator of nuclear processes and stress signaling. Because PI5P levels are tightly controlled and its production is transient, the enzyme(s) responsible for this activity have been challenging to identify, but genetic and biochemical studies have pointed to PIKFYVE as a major source in mammalian cells. Researchers study GO:0052810 to understand how cells generate and interpret PI5P signals, and to explore therapeutic opportunities in cancer, metabolic disorders, and rare diseases linked to phosphoinositide imbalance.

1-phosphatidylinositol-5-kinase activity (GO:0052810) is a molecular function defined by the catalytic reaction: a 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 5-phosphate + ADP + H+. In plain terms, it is an enzyme that adds a phosphate group to the fifth carbon of the inositol headgroup of phosphatidylinositol, using ATP as the phosphate donor and releasing ADP and a proton.

1-phosphatidylinositol-5-kinase activity is important because it generates PI5P, a lipid messenger that regulates diverse cellular processes including chromatin remodeling, transcription, endosomal trafficking, and stress responses. Dysregulation of this activity has been linked to cancer, metabolic disorders, and developmental defects, making it a potential therapeutic target.

The following genes encode proteins that either possess 1-phosphatidylinositol-5-kinase activity or directly regulate it, based on published literature.

1-phosphatidylinositol-5-kinase activity is regulated at multiple levels. Upstream signals such as insulin and growth factors can stimulate PI5P production, while phosphatases like MTMR2 and INPP4B counteract it. The PIKFYVE complex, including VAC14 and FIG4, is essential for its activity and is regulated by phosphorylation and membrane recruitment. Additionally, cellular stress and energy status via AMPK and mTOR pathways can influence PI5P levels.

Altered 1-phosphatidylinositol-5-kinase activity and PI5P levels have been observed in various cancers. PI5P can modulate cell survival, proliferation, and chromatin dynamics, and PIKFYVE is considered a potential therapeutic target in some tumor types.

PI5P produced by this activity has been linked to insulin signaling and glucose homeostasis. Dysregulation may contribute to insulin resistance and type 2 diabetes, making the enzyme a candidate for metabolic intervention.

Mutations in FIG4, a regulator of PIKFYVE, cause Charcot-Marie-Tooth disease and other neuropathies, highlighting the importance of PI5P metabolism in neuronal health.

PI5P is involved in endosomal trafficking and autophagy, processes critical for development. Disruption of 1-phosphatidylinositol-5-kinase activity can lead to developmental defects in model organisms.

Mass spectrometry-based lipidomics can quantify PI5P and other phosphoinositides to assess 1-phosphatidylinositol-5-kinase activity in cells and tissues.

Genome-wide CRISPR knockout or activation screens can identify genes that modulate PI5P levels or synthetic lethality with PIKFYVE loss.

Genetically encoded PI5P biosensors and fluorescence microscopy allow real-time visualization of PI5P dynamics in live cells.

In vitro kinase assays using recombinant enzyme and radiolabeled ATP measure direct 1-phosphatidylinositol-5-kinase activity and enable inhibitor testing.

Researchers studying 1-phosphatidylinositol-5-kinase activity-related genes often need to determine whether a candidate gene is causally involved in PI5P production, downstream signaling, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.

1-phosphatidylinositol-5-kinase activity (GO:0052810) is a key enzymatic function that generates the signaling lipid PI5P, influencing diverse processes from chromatin regulation to autophagy. Its dysregulation is linked to cancer, metabolic disorders, and neurodegeneration, making it a compelling research and therapeutic target. By leveraging CRISPR-based models and advanced screening technologies, researchers can uncover the precise roles of this activity and its regulators in health and disease.